Medical causes of seizures

Seizures are commonly encountered in patients who do not have epilepsy. Factors that may provoke such seizures include organ failure, electrolyte imbalance, medication and medication withdrawal, and hypersensitive encephalopathy. There is usually one underlying cause, which may be reversible in some patients. A full assessment should be done to rule out primary neurological disease. Treatment of seizures in medically ill patients is aimed at correction of the underlying cause with appropriate short-term anticonvulsant medication. Phenytoin is ineffective in the management of seizures secondary to alcohol withdrawal, and in those due to theophylline or isoniazid toxicity. Control of blood pressure is important in patients with renal failure and seizures. Non-convulsive status epilepticus should be considered in any patient with confusion or coma of unclear cause, and electroencephalography should be done at the earliest opportunity. Most ill patients with secondary seizures do not have epilepsy, and this should be explained to patients and their families. Only those patients with recurrent seizures and uncorrectable predisposing factors need long-term treatment with anticonvulsant medication.

[1]  P. Gorelick,et al.  Seizures and Renal Failures , 1994, The International journal of artificial organs.

[2]  B. Stern,et al.  Clinical implications of seizures in neurosarcoidosis. , 1991, Archives of neurology.

[3]  K. Jordan Continuous EEG and Evoked Potential Monitoring in the Neuroscience Intensive Care Unit , 1993, Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society.

[4]  R. Patchell Neurological complications of organ transplantation , 1994, Annals of neurology.

[5]  S. Ballas,et al.  The spectrum of epilepsy in sickle cell anemia , 1994, Journal of the Neurological Sciences.

[6]  J. Hoofnagle,et al.  Seizures during alpha interferon therapy. , 1996, Journal of hepatology.

[7]  I. Langmoen,et al.  Epileptogenic effect of antibiotic drugs. , 1993, Journal of neurosurgery.

[8]  C. White,et al.  Seizure Resulting from a Venlafaxine Overdose , 1997, The Annals of pharmacotherapy.

[9]  JO McNamara,et al.  Cellular and molecular basis of epilepsy , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[10]  Sanjeev V Thomas,et al.  First ever seizures in the elderly: a seven-year follow-up study , 1997, Seizure.

[11]  P. Marquet,et al.  A soldier who had seizures after drinking quarter of a litre of wine , 1996, The Lancet.

[12]  B. Koppel,et al.  Relation of Cocaine Use to Seizures and Epilepsy , 1996, Epilepsia.

[13]  J. Bonde,et al.  Temporal epileptic seizures and occupational exposure to solvents. , 1994, Occupational and environmental medicine.

[14]  F. Sharbrough,et al.  Prognostic value of myoclonus status in comatose survivors of cardiac arrest , 1994, Annals of neurology.

[15]  D. Labar,et al.  Baclofen‐induced generalized nonconvulsive status epilepticus , 1994, Annals of neurology.

[16]  L. Zieve INFLUENCE OF MAGNESIUM DEFICIENCY ON THE UTILIZATION OF THIAMINE , 1969, Annals of the New York Academy of Sciences.

[17]  L R Caplan,et al.  A reversible posterior leukoencephalopathy syndrome. , 1996, The New England journal of medicine.

[18]  F. Sharbrough,et al.  New‐onset seizures in critically ill patients , 1993, Neurology.

[19]  M. Beccari Seizures in Dialysis Patients Treated with Recombinant Erythropoietin. Review of the Literature and Guidelines for Prevention , 1994, The International journal of artificial organs.

[20]  J. Clinton,et al.  Haloperidol for sedation of disruptive emergency patients. , 1987, Annals of emergency medicine.

[21]  D. Lowenstein,et al.  Seizures associated with recreational drug abuse , 1989, Neurology.

[22]  R. Schwartz,et al.  MDMA (ecstasy) and the rave: a review. , 1997, Pediatrics.

[23]  M. Swenson,et al.  Cerebrovascular complications of L‐asparaginase therapy , 1988, Neurology.

[24]  W. Hauser,et al.  Illicit drug use and the risk of new-onset seizures. , 1990, American journal of epidemiology.

[25]  O. Devinsky,et al.  Clozapine‐related seizures , 1991, Neurology.

[26]  G. Celesia,et al.  Generalized status myoclonicus in acute anoxic and toxic-metabolic encephalopathies. , 1988, Archives of neurology.

[27]  T. Bleck,et al.  Neurologic complications of critical medical illnesses , 1993, Critical care medicine.

[28]  J. Pellock,et al.  Determinants of Mortality in Status Epilepticus , 1994, Epilepsia.

[29]  E. Salloum,et al.  Chlorambucil‐induced seizures , 1997, Cancer.

[30]  S. Lipton,et al.  Excitatory amino acids as a final common pathway for neurologic disorders. , 1994, The New England journal of medicine.

[31]  M. Avoli,et al.  Epileptiform activity induced by low extracellular magnesium in the human cortex maintained in vitro , 1991, Annals of neurology.

[32]  M. Rosenblum,et al.  Anti‐Hu-Associated Paraneoplastic Encephalomyelitis/Sensory Neuronopathy A Clinical Study of 71 Patients , 1992, Medicine.

[33]  M. J. Sutherland,et al.  Propofol and Seizures , 1994, Anaesthesia and intensive care.

[34]  W. Hall,et al.  The alcohol withdrawal syndrome , 1997, The Lancet.

[35]  M. Dichter,et al.  Cellular mechanisms of epilepsy: a status report. , 1987, Science.

[36]  E. Lor,et al.  Neurologic Sequelae Associated with Foscarnet Therapy , 1994, The Annals of pharmacotherapy.

[37]  J. Brust,et al.  Hypoglycemia: Causes, neurological manifestations, and outcome , 1985, Annals of neurology.

[38]  Y. Harati Diabetes and the nervous system. , 1996, Endocrinology and metabolism clinics of North America.

[39]  S. Daniels,et al.  Convulsions in children undergoing renal transplantation. , 1989, The Journal of pediatrics.

[40]  T. Martin,et al.  Life-threatening Theophylline Toxicity is Not Predictable by Serum Levels , 1987 .

[41]  M. Kirk,et al.  Pearls, pitfalls, and updates in toxicology. , 1997, Emergency medicine clinics of North America.

[42]  J. Boggs Seizures in Medically Complex Patients , 1997, Epilepsia.

[43]  N. Delanty,et al.  Erythropoietin-associated hypertensive posterior leukoencephalopathy , 1997, Neurology.

[44]  C. Bodian,et al.  Metabolic Abnormalities and New‐Onset Seizures in Human Immunodeficiency Virus‐Seropositive Patients , 1995, Epilepsia.

[45]  S. Fahn,et al.  Diagnostic guidelines in central nervous system Whipple's disease , 1996, Annals of neurology.

[46]  Len A. Pennacchio,et al.  Mutations in the Gene Encoding Cystatin B in Progressive Myoclonus Epilepsy (EPM1) , 1996, Science.

[47]  Arthur J. L. Cooper,et al.  Accidental ingestion of Ecstasy by a toddler: unusual cause for convulsion in a febrile child. , 1997, Journal of accident & emergency medicine.

[48]  P. Staats,et al.  Seizure after withdrawal from supratherapeutic doses of zolpidem tartrate, a selective omega I benzodiazepine receptor agonist. , 1997, Journal of pain and symptom management.

[49]  S. Dawling,et al.  Toxicity and deaths from 3,4-methylenedioxymethamphetamine ("ecstasy") , 1992, The Lancet.

[50]  M. Earnest,et al.  Seizure Admissions to a City Hospital: The Role of Alcohol , 1976, Epilepsia.

[51]  P. Garcia,et al.  Drug-induced seizures. , 1994, Neurologic clinics.

[52]  J. Deanfield,et al.  Neurological aspects of hyponatraemia , 1982, Postgraduate medical journal.

[53]  H. Kehlet,et al.  Postoperative sleep disturbances: mechanisms and clinical implications. , 1996, British journal of anaesthesia.

[54]  C. Ballow,et al.  Seizure Activity Associated with Imipenem Use: Clinical Case Reports and Review of the Literature , 1991, DICP : the annals of pharmacotherapy.

[55]  R. Whang,et al.  Magnesium Homeostasis and Clinical Disorders of Magnesium Deficiency , 1994, The Annals of pharmacotherapy.

[56]  T. Kunisaki,et al.  Drug- and toxin-induced seizures. , 1994, Emergency medicine clinics of North America.

[57]  B. Benson,et al.  Prospective multicenter evaluation of tramadol exposure. , 1997, Journal of toxicology. Clinical toxicology.

[58]  L. Forsgren,et al.  Epidemiology and Clinical Characteristics of Seizures in Patients with Acute Intermittent Porphyria , 1996, Epilepsia.

[59]  M. Repetto Habitual, toxic, and lethal concentrations of 103 drugs of abuse in humans. , 1997, Journal of toxicology. Clinical toxicology.

[60]  R. Dingledine,et al.  Potassium-induced spontaneous electrographic seizures in the rat hippocampal slice. , 1988, Journal of neurophysiology.

[61]  E S Freedland,et al.  Alcohol-related seizures, Part II: Clinical presentation and management. , 1993, The Journal of emergency medicine.

[62]  Pellegrino Tr An emergency department approach to first-time seizures. , 1994 .

[63]  C. R. Harris,et al.  Fatal bupropion overdose. , 1997, Journal of toxicology. Clinical toxicology.

[64]  E. Freedland,et al.  Alcohol-related seizures, Part I: Pathophysiology, differential diagnosis, and evaluation. , 1993, The Journal of emergency medicine.

[65]  M. Avoli,et al.  Functional and pharmacological properties of GABA-mediated inhibition in the human neocortex. , 1997, Canadian journal of physiology and pharmacology.

[66]  Mark F. Newman,et al.  Adverse Cerebral Outcomes after Coronary Bypass Surgery , 1996 .

[67]  J. Jefferys,et al.  Low‐calcium field burst discharges of CA1 pyramidal neurones in rat hippocampal slices. , 1984, The Journal of physiology.

[68]  Joseph F Chance Emergency department treatment of alcohol withdrawal seizures with phenytoin. , 1991, Annals of emergency medicine.

[69]  E. Favale,et al.  Anticonvulsant effect of fluoxetine in humans , 1995, Neurology.

[70]  M. Balzan,et al.  Carbon monoxide poisoning: easy to treat but difficult to recognise. , 1996, Postgraduate medical journal.

[71]  J. Wood,et al.  THE EFFECT ON GABA METABOLISM IN BRAIN OF ISONICOTINIC ACID HYDRAZIDE AND PYRIDOXINE AS A FUNCTION OF TIME AFTER ADMINISTRATION , 1972, Journal of neurochemistry.

[72]  N. Hagen,et al.  Strychnine-like multifocal myoclonus and seizures in extremely high-dose opioid administration: treatment strategies. , 1997, Journal of pain and symptom management.

[73]  P. Meissner,et al.  The acute porphyrias , 1997, The Lancet.

[74]  K. Leveno,et al.  A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia. , 1995, The New England journal of medicine.

[75]  D. Turnbull,et al.  Clinical features, investigation, and management of patients with defects of mitochondrial DNA , 1997, Journal of neurology, neurosurgery, and psychiatry.

[76]  M. Dragunow,et al.  Status epilepticus may be caused by loss of adenosine anticonvulsant mechanisms , 1994, Neuroscience.

[77]  D. Labar,et al.  Seizures in human immunodeficiency virus infection. , 1990, Archives of neurology.

[78]  I. Mitchell,et al.  Cerebral lupus Report of a Meeting of Physicians, United Medical and Dental Schools of Guy's and St Thomas' Hospitals and Guy's Hospital, London , 1994, The Lancet.

[79]  I. Scheffer,et al.  Genetics of human partial epilepsy. , 1997, Current opinion in neurology.

[80]  R. Wiesner,et al.  Causes and outcome of seizures in liver transplant recipients , 1996, Neurology.

[81]  M. Stecker,et al.  Treatment of Refractory Status Epilepticus with Propofol: Clinical and Pharmacokinetic Findings , 1998, Epilepsia.

[82]  Kenneth G. Jordan,et al.  An assessment of nonconvulsive seizures in the intensive care unit using continuous EEG monitoring , 1996, Neurology.

[83]  J. Henry,et al.  Treatment of theophylline overdose. , 1996, The American journal of emergency medicine.

[84]  I. Scheffer,et al.  A missense mutation in the neuronal nicotinic acetylcholine receptor α4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy , 1995, Nature Genetics.

[85]  E. Wyllie,et al.  The Treatment of Epilepsy: Principles and Practice , 1997 .

[86]  K. Kizer Domoic acid poisoning. , 1994, The Western journal of medicine.

[87]  D. Hosford,et al.  Generalized epilepsies: emerging insights into cellular and genetic mechanisms. , 1997, Current opinion in neurology.

[88]  J. Engel,et al.  Overview of seizures. , 1994, Emergency medicine clinics of North America.

[89]  D. Lowenstein,et al.  Placebo-controlled trial of intravenous diphenylhydantoin for short-term treatment of alcohol withdrawal seizures. , 1989, The American journal of medicine.

[90]  J. Brust,et al.  Marijuana use and the risk of new onset seizures. , 1992, Transactions of the American Clinical and Climatological Association.

[91]  S. Amann,et al.  Stevens-Johnson syndrome resulting from whole-brain radiation and phenytoin. , 1996, American journal of clinical oncology.

[92]  P. Kaplan Nonconvulsive Status Epilepticus in the Emergency Room , 1996, Epilepsia.

[93]  S. Berkovic,et al.  Poppy tea and the baker's first seizure , 1997, The Lancet.

[94]  P. Moore Neuropsychiatric Systemic Lupus Erythematosus , 1997, Annals of the New York Academy of Sciences.

[95]  L. Richardson,et al.  The evaluation and treatment of seizures in the emergency department. , 1997, The Mount Sinai journal of medicine, New York.

[96]  S. Pacia,et al.  The prolonged QT syndrome presenting as epilepsy , 1994, Neurology.

[97]  J. French Pseudoseizures in the era of video‐electroencephalogram monitoring , 1995, Current opinion in neurology.

[98]  Massimo Avoli,et al.  GABA and Epileptogenesis , 1997, Epilepsia.

[99]  S. Small,et al.  Immunosuppression‐induced leukoencephalopathy from tacrolimus (FK506) , 1996, Annals of neurology.

[100]  R. Konaka,et al.  Generation of lipid radicals in the hippocampal extracellular space during kainic acid-induced seizures in rats , 1997, Epilepsy Research.

[101]  N. White,et al.  Convulsions in childhood malaria. , 1994, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[102]  J. Hopper,et al.  Early seizures after acute stroke. Risk of late seizures. , 1992, Archives of neurology.

[103]  R. Thomas,et al.  Seizures and epilepsy in the elderly. , 1997, Archives of internal medicine.